BiotechTube
Home/Capsigen/Charlie Kang
CK

Charlie Kang

Chief Business Officer

Capsigen

Therapeutic Areas

CNS DisordersNeuromuscular Disorders

Capsigen Pipeline

DrugIndicationPhase
Biogen Collaboration - Capsid EngineeringCNS and Neuromuscular DisordersResearch/Pre-clinical
CGN-1 Neurotropic CapsidNeurological Disorders (Proof-of-Concept)Pre-clinical

Leadership Team at Capsigen

JB
John Bial
Chief Executive Officer
HN
Hiroyuki Nakai
Chief Science Officer
View full Capsigen profile